期刊文献+

肝硬化患者血清生化指标的表达及临床意义

Expression and Clinical Significance of Serum Biochemical indexes in Patients with Liver Cirrhosis
下载PDF
导出
摘要 目的探讨肝硬化患者血清生化指标的表达和临床价值。方法选取2016年11月至2018年2月本院收治的肝硬化患者60例作为观察组,选取同期健康体检人员60名作为对照组。两组受试人员均给予血清生化指标检测,观察对比两组受试人员血清网膜素、脂联素与内脏脂肪素指标水平情况。结果观察组患者的血清网膜素、脂联素的水平分别是(924.6±20.6)ng/L、(904.8±21.8)ng/L,显著高于对照组[(728.5±56.4)、(650.8±42.9)ng/L,P <0.05],组间比较差异有统计学意义(P <0.05)。结论肝硬化症状发生时患者的网膜素、脂联素水平会有升高的现象,内脏的脂肪素也会下降,能够作为肝硬化预测指标,但是无法有效评估肝功能的严重程度。 Objective To investigate the expression and clinical value of serum biochemical indexes in patients with liver cirrhosis. Methods Sixty cases of liver cirrhosis in our hospital from November 2016 to February2018 were selected as the observation group,and 60 healthy persons in the same period were selected as the control group. The serum biochemical indexes were detected in the two groups,and the levels of the serum omentin,adiponectin and visceral adiponectin were observed and compared in the two groups. Results The serum levels of omentin and adiponectin in the observation group were 924.6±20.6 and 904.8± 21.8 ng/L,respectively,significantly higher than those in the control group,and there was a significant difference between the two groups(728.5±56.4,650.8±42.9 ng/L,P<0.05). Conclusion The level of retinin and adiponectin in patients with hepatocirrhosis may increase,and the level of adiposin in the viscera may decrease,which can be used as a predictor of cirrhosis,but the severity of liver function may not be evaluated effectively.
作者 高忠波 GAO Zhongbo(Jianhu County Maternal and Child Health Family Planning Service Center,Yancheng,Jiangsu 224700,China)
出处 《大医生》 2018年第11期97-98,共2页 Doctor
关键词 肝硬化 血清 生化指标 胰岛素 临床价值 探究 liver cirrhosis serum biochemical indicators insulin clinical value exploration
  • 相关文献

参考文献11

二级参考文献87

  • 1邱轶伟,马涛,吴双虎,薛承锐.大黄素收缩大鼠结肠平滑肌细胞的信号转异机制研究[J].天津医科大学学报,2005,11(2):205-207. 被引量:6
  • 2中华医学会肝脏病学分会脂肪肝和酒精性肝病学组.非酒精性脂肪肝诊疗指南[J].中华肝脏病杂志,2006;14(2) :161-2.
  • 3Mcfarlane I G. Autoimmune liver diseases[J].Scand J Clin Invest,2001,(suppl 235):53-60.
  • 4韩英.原发性胆汁性肝硬化-自身免疫性肝炎重叠综合征的诊治进展[A],201268.
  • 5Johnson P J,Mcfarlane I G. Meeting report:International autoimmune hepatitis group[J].{H}HEPATOLOGY,1993,(02):998-1005.
  • 6Hennes E M,Zeniya M,Czaja A J. Simplified criteria for the diagnosis of autoimmune hepatitis[J].{H}HEPATOLOGY,2008,(01):169-176.
  • 7Carlo Selmi,Christopher L B,Gershwin M. Primary biliary cirrhosis[J].{H}LANCET,2011,(04):1600-1609.
  • 8Heathcote E J. Management of primary biliary cirrhosis[J].{H}HEPATOLOGY,2000,(05):1005-1013.
  • 9Czaja A J. The variant forms of autoimmune hepatitis[J].{H}ANNALS OF INTERNAL MEDICINE,1996,(02):588-598.
  • 10Chazouilleres O,Wendum D,Serfaty L. Primary biliary cirrhosis-autoimmune hepatitis overlap syndrome:Clinical features and response to therapy[J].{H}HEPATOLOGY,1998,(04):296-301.

共引文献116

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部